Market for Rx-to-OTC Switches, 3rd Edition, The

Table of Contents

Executive Summary

• Scope and Methodology
• Size and Growth of the Market
• Issues and Trends Affecting the Rx-to-OTC Switches Market
• Leading Competitors

Introduction

• Overview of the Over-the-Counter Market
• Development of the Rx-to-OTC Drug Market
• Rx-to-OTC Industry Structure

Allergy, Cough, Cold, And Sinus Products

• Overview
  • Antihistamines
  • Decongestants
  • Cough Preparations
  • Mast Cell Stabilizers
  • Ophthalmic Preparations
• Description of Conditions
  • Allergic Rhinitis
  • Common Cold
  • Sinusitis
  • Hives
  • Ocular Allergies
• Prevalence and Incidence
• Product Analysis
  • Current OTC Switched Products
  • Prescription Products with Anticipated OTC Approvals
• Market Analysis
  • Market Size and Forecast
  • Competitive Analysis

Analgesics, NSaids, And Topical Pain Relievers

• Overview
  • Analgesics
  • Nonsteroidal Anti-inflammatory Drugs
  • Topical Pain Relievers and Other Similar Products
• Description of Conditions
  • Pain
  • Inflammation
• Prevalence and Incidence
• Product Analysis
  • Current OTC Switched Products
  • Prescription Products with Anticipated OTC Approvals
• Market Analysis
  • Market Size and Forecast
  • Competitive Analysis

Anti-Infectives

• Overview
  • Antibiotics
  • Antifungals
  • Antivirals
  • Antiparasitics
• Description of Conditions
  • Vaginal Infections
  • Athlete’s Foot
  • Jock Itch
  • Ringworm
  • Dandruff
  • Scabies and Pediculosis
  • Pinworm
• Prevalence and Incidence
• Product Analysis
  • Current OTC Switched Products
  • Prescription Products with Anticipated OTC Approvals
• Market Analysis
  • Market Size and Forecast
  • Competitive Analysis

Gastrointestinal Drugs

• Overview
• Description of Conditions
  • Nausea
  • Diarrhea
  • Heartburn
  • Acid reflux
• Prevalence and Incidence
• Product Analysis
  • Current OTC Switched Products
  • Prescription Products with Anticipated OTC Approvals
• Market and Competitive Analysis
  • Market Size and Forecast
  • Competitive Analysis

Smoking Cessation

• Overview
• Description of Conditions
• Prevalence and Incidence
• Product Analysis
  • Current OTC Switched Products
  • Prescription Products with Anticipated OTC Approvals
• Market Analysis
  • Market Size and Forecast
  • Competitive Analysis

Miscellaneous Drugs

• Overview
  • Dental Rinses and Fluorides
  • Hair Growth Products
  • Rectal Ointments
  • Sleep Aids
• Description of Conditions
  • Dental Carries
  • Hereditary Hair Loss
  • Hemorrhoids
  • Sleeplessness
• Conditions with Possible Future OTC Treatments
  • Elevated Cholesterol
  • Osteoporosis
  • Acne Vulgaris
  • Menopause and Hormone Replacement
  • Pregnancy Prevention
• Prevalence and Incidence
• Product Analysis
  • Current OTC Switched Products
  • Prescription Products with Anticipated OTC Approvals
• Market Analysis
  • Market Size and Forecast
  • Competitive Analysis

Total Market Summary

• Overview
• Total market Size and Forecast
  • Markets by Segments
• Competitive Analysis
• Market Analysis

Issues And Trends Affecting The Rx-To-OTC Market

• Introduction
• Regulatory Authorities
• A Third Class of Drug
• Impact on the Insurance Company
• Pharmacists Role
• Impact on the Prescription Drug Manufacturer
• Strategies for Continued Product Growth—Dual Status Switching
• Impact on the Consumer
  • Direct-to-Consumer Advertising
  • Consumer Purchasing Trends
• Patent Expiration
• Labeling Changes

Company Profiles

Brand Company Profiles

• Bayer Consumer Care
• GlaxoSmithKline Consumer Healthcare
• Johnson & Johnson
• Merck Consumer Pharmaceuticals Company
• McNeil Consumer & Specialty Pharmaceuticals
• Novartis Consumer Health, Inc.
• Personal Products Company
• Pfizer Consumer Healthcare
• Pharmacia Consumer Healthcare
• Procter & Gamble Company, Health Care Division
• Schering-Plough HealthCare Products
• Wyeth Consumer Health Care

Generic and Private Label Company Profiles

• Alpharma U.S. Human Pharmaceuticals (USHP)
• IVAX Pharmaceuticals, Inc.
• Perrigo Company
• Watson Pharmaceuticals, Inc.

Company Directory

List of Exhibits

Chapter One: Executive Summary

• Table 1-1: The Total U.S. Market for Over-the-Counter Switches 1997-2007
• Figure 1-1: The U.S. Market for Rx-to-OTC Switches Revenues by Type 1997-2007
• Table 1-2: Leading Suppliers’ Significant Segments of Participation within the U.S. Market for Rx-to-OTC Switches, 2002

Chapter Two: Introduction

• Table 2-1: OTC Retail Sales, 1976-2001
• Table 2-2: Rx-to-OTC Switches Approved by the FDA 1976-2003
• Table 2-3: Statistics for Selected Rx-to-OTC Switches
• Table 2-4: Estimated OTC Sales by Product Type and Percent of Sales Attributed to Rx-to-OTC Switched Ingredients
• Table 2-5: U.S. Population by Sex and Selected Age Group, 1997-2017
• Table 2-6: Healthcare Industry Inflation Rates Healthcare Industry Consumer Price Index Comparisons Based on 2002 Data
• Figure 2-1: Healthcare Industry Inflation Rates Healthcare Industry Consumer Price Index Comparisons Based on 2002 Data

Chapter Three: Allergy, Cough, Cold, And Sinus Products

• Table 3-1: United States Incidence of Allergy, Cough, Cold, Sinus Conditions 2002
• Figure 3-1: United States Incidence of Allergy, Cough, Cold, Sinus Conditions, Superimposed on Total Population, 2002
• Table 3-2: Allergy, Cough, Cold, Sinus Product Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval
• Table 3-3: Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
• Table 3-4: The U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold, and Sinus Product Revenues 1997-2007
• Figure 3-2: The U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold, and Sinus Product Revenues 1997-2007
• Table 3-5: The U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold, and Sinus Products Revenues by Type 1997-2007
• Table 3-6: The U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold, and Sinus Products Distribution of Revenues by Product Type 1997-2007
• Figure 3-3: The U.S. Market for Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, by Product Type and Revenues, 1997-2007
• Figure 3-4: The U.S. Market for Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, by Percent and Product Type, 2002
• Table 3-7: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, 2002
• Figure 3-5: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, 2002

Chapter Four: Analgesics, Nsaids, And Topical Pain Relievers

• Table 4-1: United States Incidence of Conditions with Pain and Inflammatory Symptoms 2002
• Figure 4-1: United States Incidence of Conditions with Pain and Inflammatory Symptoms Superimposed on Total Population, 2002
• Table 4-2: Analgesics, NSAIDs and Other Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval
• Table 4-3: Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
• Table 4-4: The U.S. Market for Rx-to-OTC Switches Analgesics, NSAIDs, and Other Drugs Total Revenues 1997-2007
• Figure 4-2: The U.S. Market for Rx-to-OTC Switches: Analgesics, NSAIDs, and Other Drugs, 1997-2007
• Table 4-5: The U.S. Market for Rx-to-OTC Switches Analgesics, NSAIDs, and Other Drugs Revenues by Product Type 1997-2007
• Table 4-6: The U.S. Market for Rx-to-OTC Switches Analgesics, NSAIDs, and Other Drugs Distribution of Revenues by Product Type 1997-2007
• Figure 4-3: The U.S. Market for Rx-to-OTC Switches Analgesics, NSAIDs, and Other Drugs Revenues by Product Type 1997-2007
• Figure 4-4: The U.S. Market for Rx-to-OTC Switches Analgesics, NSAIDs, and Other Drugs Distribution of Revenues by Product Type 2002
• Table 4-7: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Analgesics, NSAIDs, and Other Drugs 2002
• Figure 4-5: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Analgesics, NSAIDs, and Other Drugs 2002

Chapter Five: Anti-Infectives

• Table 5-1: United States Yearly Incidence of Infections, 2002
• Figure 5-1: United States Yearly Incidence of Infections Superimposed on Total Population, 2002
• Table 5-2: Anti-infectives Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval
• Table 5-3: Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
• Table 5-4: The U.S. Market for Rx-to-OTC Switches Anti-infectives 1997-2007
• Figure 5-2: The U.S. Market for Rx-to-OTC Switches Anti-infectives, 1997-2007
• Table 5-5: The U.S. Market for Rx-to-OTC Switches Anti-infectives by Product Type 1997-2007
• Table 5-6: The U.S. Market for Rx-to-OTC Switches, Anti-infectives Distribution of Revenues by Product Type 1997-2007
• Figure 5-3: The U.S. Market for Rx-to-OTC Switches Anti-infectives by Product Type, 1997-2007
• Figure 5-4: The U.S. Market for Rx-to-OTC Switches, Anti-infectives Revenue Distribution by Product Type 2002
• Table 5-7: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switched Anti-infectives 2002
• Figure 5-5: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switched Anti-infectives 2002

Chapter Six: Gastrointestinal Drugs

• Table 6-1: United States Incidence of Gastrointestinal Conditions 2002
• Figure 6-1: United States Incidence of Gastrointestinal Conditions Superimposed on General Population 2002
• Table 6-2: Gastrointestinal Drug Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval
• Table 6-3: Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
• Table 6-4: The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs 1997-2007
• Figure 6-2: The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs 1997-2007
• Table 6-5: The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs by Product Type 1997-2007
• Table 6-6: The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs Distribution of Revenues by Product Type 1997-2007
• Figure 6-3: The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs by Product Type 1997-2007
• Figure 6-4: The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs Distribution of Revenues by Product Type 2002
• Table 6-7: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs 2002
• Figure 6-5: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs 2002

Chapter Seven: Smoking Cessation

• Table 7-1: United States Cigarette Usage in Percent by Age Group, 2002
• Figure 7-1: United States Cigarette Usage in Percent by User Type 2002
• Table 7-2: Lung Cancer in the United States Estimated New Cases and Deaths 2002
• Table 7-3: Smoking Cessation Product Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval
• Table 7-4: Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
• Table 7-5: The U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs 1997-2007
• Figure 7-2: The U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs 1997-2007
• Table 7-6: The U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs Revenues by Product Type 1997-2007
• Table 7-7: The U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs Distribution of Revenues by Product Type 1997-2007
• Figure 7-3: The U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs Revenues by Product Type 1997-2007
• Figure 7-4: The U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs Distribution of Revenue by Product Type 2002
• Table 7-8: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs 2002
• Figure 7-5: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs 2002

Chapter Eight: Miscellaneous Drugs

• Table 8-1: United States Incidence of Miscellaneous Conditions for Which There Are Potential Rx-to-OTC Switches 2002
• Table 8-2: Miscellaneous Drug Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval
• Table 8-3: Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
• Table 8-4: The U.S. Market for Rx-to-OTC Switches Miscellaneous Drugs Revenues by Product Type 1997-2007
• Table 8-5: The U.S. Market for Rx-to-OTC Switches Miscellaneous Drugs Distribution of Revenues by Product Type 1997-2007
• Figure 8-1: The U.S. Market for Rx-to-OTC Switches Miscellaneous Drugs Revenues by Product Type 1997-2007
• Figure 8-2: The U.S. Market for Rx-to-OTC Switches Miscellaneous Dugs Distribution of Revenues by Product Type 2002
• Table 8-6: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Miscellaneous Drugs 2002
• Figure 8-3: Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Miscellaneous Drugs 2002

Chapter Nine: Total Market Summary

• Table 9-1: The U.S. Market for Rx-to-OTC Switches 1997-2007
• Figure 9-1: The U.S. Market for Rx-to-OTC Switches, 1997-2007
• Table 9-2: The U.S. Market for Rx-to-OTC Switches by Type, 1997-2007
• Table 9-3: The U.S. Market for Rx-to-OTC Switches Revenue Distribution by Segment 1997-2007
• Figure 9-2: The U.S. Market for Rx-to-OTC Switches by Type and Revenues, 1997-2007
• Figure 9-3: The U.S. Market for Rx-to-OTC Switches by Type and Percent Distribution, 1997-2007
• Figure 9-4: The U.S. Market for Rx-to-OTC Switches by Percent and Segment, 2002
• Table 9-4: Leading Suppliers Significant Segments of Participation within the U.S. Market for Rx-to-OTC Switches, 2002

Chapter Ten: Issues and Trends Affecting the Rx-to-OTC Market

Figure 10-1: Typical Pharmacist-Consumer OTC Drug Counseling Session

Table 10-1: Health Insurance Coverage Status by Selected Characteristics, 1990-2000

Table 10-2: Average Annual Expenditures per Consumer Unit for Healthcare 1990-2000

Table 10-3: Estimated Direct-to-Consumer Advertising Expenditures by Drug and Marketer